FEATURES OF BONE METABOLISM AND THE ROLE OF MRI IN THE DIAGNOSIS OF CHARCOT'S FOOT IN PATIENTS WITH TYPE 2 DIABETES MELLITUS

被引:0
|
作者
Kamalov, T. T. [1 ]
Tojiboev, S. S. [2 ]
Shokirov, Kh. Sh. [2 ]
Talanova, V. A. [2 ]
机构
[1] Acad EKh Turakulov, Minist Hlth Republ Uzbekistan, Republican Specialized Sci & Pract Med Ctr Endocr, Dept Diabet Foot, Tashkent, Uzbekistan
[2] Acad EH Turakulov, Minist Hlth Republ Uzbekistan, Republican Specialized Sci & Pract Med Ctr Endocr, Dept Diabet Foot, Tashkent, Uzbekistan
关键词
MINERAL DENSITY;
D O I
10.9756/INTJECSE/V14I2.908
中图分类号
G76 [特殊教育];
学科分类号
040109 ;
摘要
The aim of the study was to study the role of MRI and the state of bone metabolism in the diagnosis of Charcot's foot in patients with diabetic osteoarthropathy at an early stage. Research materials and methods: 45 patients were examined (prospectively) with type 2 diabetes and Charcot's foot in the period 2021-2022 at the Academician E.H. Turakulov Endocrinology Research Center , in the department of diabetic foot. All observed patients were divided into 4 groups: 1 gy - patients with acute stage of Charcot's foot with type 2 diabetes - 25 patients, Group 2 - patients with the subacute stage of Charcot's foot - 20 patients, The control group consisted of 20 persons with DM 2 without VDS. Of the 45 patients, there were 37 men and 8 women. The average age: men was 69.12 years, women - 68, 15 years. The prescription of type 2 diabetes ranged from 17 to 25 years. The research methods included: biochemical (bilirubin, direct, indirect, lipid spectrum, ALT, AST, PTI, coagulogram, blood sugar, glycated hemoglobin, urea, creatinine, GFR, calcium, alkaline phosphatase, parathyroid hormone, vitamin D3, blood and instrumental: ECG, MRI of the feet, dopplerography of the main vessels of the legs, Ultrasound of internal organs, DEHA, fundus. The results of the study. On the MRI, we found the location of the bone marrow abnormality (edema shown in fluid-sensitive and recovery of fatty bone marrow shown in T1 sequences). The pattern tended to be periarticular. All patients had several joints and bones involved (mainly tarsometatarsal joints and metatarsal joints). In the late stages of Charcot's foot, the appearance of severe pathological changes (bone destruction, massive effusion, etc.) is characteristic on MRI. Early stage of Charcot's foot CT (computed tomography) It does not play an important role for visualization, since changes in bone marrow and soft tissues can be better visualized using MRI ( magnetic resonance imaging). CT can be used in the later stage of Charcot's foot for better visualization of bone proliferation and consolidation. Diagnosis of this disease in the early stages contributes to the timely initiation of appropriate therapy and helps to minimize the disability of these patients. In the late stages of Charcot's foot, the appearance of severe pathological changes (bone destruction, massive effusion, etc.) is characteristic on MRI Conclusions 1. Patients with diabetic foot syndrome complicated by Charcot's foot are at high risk of deficiency of 25-hydroxyvitamin D3 and calcium. 2) An early symptom on MRI with Charcot's foot was the presence of concavity of the articular surface of the talus bone against the background of sclerosis in the talus-navicular joint.
引用
收藏
页码:8079 / 8086
页数:8
相关论文
共 50 条
  • [41] BONE QUALITY ASSESSMENT IN PATIENTS WITH TYPE 2 DIABETES MELLITUS
    Hanouchine, Nassima
    Ouhadj, Salah
    Dahou-Makhloufi, Chafia
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 931 - 932
  • [42] Type 2 diabetes mellitus and bone
    Compston, J.
    JOURNAL OF INTERNAL MEDICINE, 2018, 283 (02) : 140 - 153
  • [43] Drugs for type 2 diabetes: role in the regulation of bone metabolism
    Mannucci, Edoardo
    Dicembrini, Ilaria
    CLINICAL CASES IN MINERAL AND BONE METABOLISM, 2015, 12 (02) : 130 - 134
  • [44] Effect of oral hypoglycaemic agents on bone metabolism in patients with type 2 diabetes mellitus & occurrence of osteoporosis
    Kumar, B. Siddhartha
    Ravisankar, A.
    Mohan, Alladi
    Kumar, D. Prabath
    Katyarmal, D. T.
    Sachan, Alok
    Sarma, K. V. S.
    INDIAN JOURNAL OF MEDICAL RESEARCH, 2015, 141 : 431 - 437
  • [45] The Effect of DPP-4 Inhibitor, Alogliptin, on Bone Metabolism in Patients With Type 2 Diabetes Mellitus
    Yamauchi, Yuichiro
    Tunekawa, Shin
    Seino, Yusuke
    Uenishi, Eita
    Okawa, Tetuji
    Fujiya, Atushi
    Ishikawa, Kouta
    Ogata, Hidetada
    Iida, Atushi
    Banno, Ryoichi
    Arima, Hiroshi
    Hamada, Yoji
    Oiso, Yutaka
    DIABETES, 2013, 62 : A276 - A277
  • [46] Glycemic control and bone metabolism in postmenopausal women with type 2 diabetes mellitus
    Terano, Takashi
    Suzuki, Sawako
    Yoshida, Tomohiko
    Nagano, Hidekazu
    Hashimoto, Naoko
    Mayama, Takafumi
    Koide, Hisashi
    Suyama, Keiko
    Tanaka, Tomoaki
    Yamamoto, Kyohei
    Tatsuno, Ichiro
    DIABETOLOGY INTERNATIONAL, 2012, 3 (02) : 68 - 74
  • [47] Update on the impact of type 2 diabetes mellitus on bone metabolism and material properties
    Picke, Ann-Kristin
    Campbell, Graeme
    Napoli, Nicola
    Hofbauer, Lorenz C.
    Rauner, Martina
    ENDOCRINE CONNECTIONS, 2019, 8 (03): : R55 - R70
  • [48] Glycemic control and bone metabolism in postmenopausal women with type 2 diabetes mellitus
    Takashi Terano
    Sawako Suzuki
    Tomohiko Yoshida
    Hidekazu Nagano
    Naoko Hashimoto
    Takafumi Mayama
    Hisashi Koide
    Keiko Suyama
    Tomoaki Tanaka
    Kyohei Yamamoto
    Ichiro Tatsuno
    Diabetology International, 2012, 3 (2) : 68 - 74
  • [49] Brain lesions on MRI in elderly patients with type 2 diabetes mellitus
    van Harten, Barbera
    Oosterman, Joukje M.
    van Loon, Bert-Jan Potter
    Scheltens, Philip
    Weinstein, Henry C.
    EUROPEAN NEUROLOGY, 2007, 57 (02) : 70 - 74
  • [50] Nomogram Prediction for the Risk of Diabetic Foot in Patients With Type 2 Diabetes Mellitus
    Wang, Jie
    Xue, Tong
    Li, Haopeng
    Guo, Shuai
    FRONTIERS IN ENDOCRINOLOGY, 2022, 13